New vaccination strategies;Nouvelles stratégies de la vaccination

Bulletin de l'Academie Nationale de Medecine

Volumn 192, Issue 3, 2008, Pages 511-519

  Plotkin, Stanley A ^a  

^a SANOFI PASTEUR   (France)

Author keywords

DNA; Eassortant viruses; Genetic vectors; Vaccines

Indexed keywords

VACCINE;

BACTERIAL INFECTION; HUMAN; REVIEW; VACCINATION; VIRUS INFECTION;

BACTERIAL INFECTIONS; HUMANS; VACCINATION; VACCINES; VIRUS DISEASES;

EID: 55249122276     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)32809-2     Document Type: Article

References (8)

1. CLARK H. F., OFFIT P. A., PLOTKIN S. A., HEATON P. M.-The new pentavalent rotavirus vaccine composed of bovine (strain WC3) -human rotavirus reassortants. Ped. Infect. Dis. J., 2006, 25, 577-583.
2. BELSHE R., LEE M. S., WALKER R. E. ET al. - Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine. Expert Rev. Vaccines, 2004, 3, 643-54.
3. LEE M. S., MAHMOOD K., ADHIKARY L., AUGUST M. J., CORDOVA J., CHO I., KEMBLE G., REISINGER K., WALKER R. E., MENDLEMAN P. M. - Pediatr. Infect. Dis. J., 2004, 23, 852-6.
4. HALLORAN M. E., LONGINI IM J. R., GAGLANI M. J., PIEDRA P. A., CHU H., HERSCHLER G. B., GLEZEN W. P. - Estimating efficacy of trivalent, cold-adapted, influenza virus vaccine (CAIV-T) against influenza A (HIN1) and B using surveillance cultures. Am. J. Epidemiol., 2003, 155, 312-5.
5. TANG R. S., MACPHAIL M., SCHICKLI J. H., KAUR J., ROBINSON C. L., LAWLOR H. A., GUZZETTA J. M., SPAETE R. R., HALLER A. A. - Parainfluenza virus type 3 expressing the native or soluble fusion (F) Protein of Respiratory Syncytial Virus (RSV) confers protection from RSV infection in African green monkeys. J. Virol., 2004, 78, 20, 11198-207.
6. BERENCSI K., GYULAI Z., GONCZOL E., PINCUS S., COX W. I., MICHELSON S., KARI L., MERIC C., CADOZ M., ZAHRADNIK J., STARR S., STANLEY PLOTKIN S. A.-A Canarypox Vector-expressing cytomegalovirus phosphoprotein 65 (pp65) Induces Long-lasting Cytotoxic T Cell Responses in HCMV Seronegative Volunteers. J. Infect. Dis., 2001, 183, 1171-9.
7. CAPECCHI B., SERRUTO D., ADU-BOBIE J., RAPPUOLI R., PIZZA M.-The genome revolution in vaccine research. Curr. Issues Mol. Biol., 2004, 6, 17-27.
8. PLOTKIN S. A. - Vaccines: past, present, and future. Nature Medicine, 2005, 11, S5-S11.